Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J v. Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Wilmington, Delaware federal court sets aside stent patent infringement award of $271.1 mil. to Johnson & Johnson, Medtronic announces April 1. In a similar patent dispute between Boston Scientific and J&J, the same federal judge set aside a jury award of $324.4 mil. (1"The Gray Sheet" April 1, 2002, In Brief). J&J plans to appeal...

You may also be interested in...



J&J v. Boston Scientific

Stent patent infringement award of $324.4 mil. to Johnson & Johnson is set aside and a new damages trial has been ordered in Wilmington federal court, Boston Scientific announces March 28. However, the court upheld a portion of a December 2000 jury verdict that found the NIR stent, made by Medinol for Boston Scientific, infringed one claim of J&J's '762 Palmaz balloon expandable stent patent (1"The Gray Sheet" Dec. 18, 2000, p. 16). "Regardless of the outcome of the new damages trial, we plan on appealing any infringement judgment entered," Boston Scientific says...

Dr Reddy's Adds To OTC Portfolio With Glenmark Deal

Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.

Sandoz Launches US Awareness Campaign

Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.

UsernamePublicRestriction

Register

OM004559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel